The rebranding strategy reflects the company’s strategic focus on advancing treatment solutions in urology and stone management for global patients.

The rebranding follows Advanced MedTech’s recent spin out from Accuron Technologies Limited, which was completed on 29 March 2019. The new name signifies the company’s streamlined operations and independence from Accuron Technologies. The organizational structure will remain the same, with no changes to the names of its wholly owned subsidiaries.

Commenting on the rebranding, Abel Ang, Group Chief Executive of Advanced MedTech said: “Rebranding as Advanced MedTech marks the start of a new chapter and highlights our commitment to continued expansion and growth. This happens at an exciting time as the group strengthens its global leadership in urology and stone management through technology innovation and investments. 2019 is set to be an exciting year as we look forward to developing and commercializing more innovative treatments, delivering above-market growth, and advancing to take on bigger challenges in global healthcare.”

Source: Company Press Release